A study on Grindelia robusta 30C in chronic brochitis by inhalation method

A Randomized Single Blind Control Trail on the Effectiveness of Grindelia robusta 30C in improving FEV1 values by Olfaction method in Chronic Bronchitis - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069445

Enrollment

Registered

2024-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J42- Unspecified chronic bronchitis

Interventions

Intervention1: Grindelia robusta 30C: Grindelia robusta 30C will be administered to the patients suffering with Chronic Bronchitis. One Dose per week through olfaction Method will be given. Patient wi

Eligibility

Inclusion criteria

Inclusion criteria: person having occupational exposure FEV1 values greater than 30 percent to 80 percent of predicted

Exclusion criteria

Exclusion criteria: chronic restrictive lung disease patients with other comorbidities like lung cancer, depression and metabolic syndrome are excluded. Taking ACE inhibitors FEV1 values less than 30 percent of predicted

Design outcomes

Primary

Measure	Time frame
Patient Spirometry fev1 values before Medication.Timepoint: 3 MONTHS	—

Secondary

Measure	Time frame
Pre & Post fev1 values will be obtained before & after medication through Spirometry. A Comparative data between interventional & control group will be obtained.Timepoint: 3 MONTHS	—

Countries

India

Contacts

Public ContactDr. T. AJAYAN

Sarada Krishna Homoeopathic Medical College

tajayandr@gmail.com9442365199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026